α-Galactosidase delivery using 30Kc19-human serum albumin nanoparticles for effective treatment of Fabry disease

Title
α-Galactosidase delivery using 30Kc19-human serum albumin nanoparticles for effective treatment of Fabry disease
Authors
Keywords
Fabry disease, Enzyme replacement therapy, Protein nanoparticle, Drug delivery, Enzyme stability
Journal
APPLIED MICROBIOLOGY AND BIOTECHNOLOGY
Volume 100, Issue 24, Pages 10395-10402
Publisher
Springer Nature
Online
2016-06-29
DOI
10.1007/s00253-016-7689-z

Ask authors/readers for more resources

Reprint

Contact the author

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started